Background
Background Disturbances in the Disturbances in the central nervous system originating during central nervous system originating during foetal life may increase the risk of foetal life may increase the risk of schizophrenia. schizophrenia.
Aims Aims To illuminate the hypothesis that
To illuminate the hypothesis that prenatal exposure to analgesics may affect prenatal exposure to analgesics may affect foetal neurodevelopment, leading to foetal neurodevelopment, leading to increased risk of schizophrenia in increased risk of schizophrenia in adulthood. adulthood.
Method Method Using data from the
Using data from the Copenhagen Perinatal Cohort and from Copenhagen Perinatal Cohort and from the Danish Psychiatric Central Register, the Danish Psychiatric Central Register, we studied the relationship between we studied the relationship between prenatal exposure to analgesics and the prenatal exposure to analgesics and the riskof schizophrenia.The effect of prenatal riskof schizophrenia.The effect of prenatal exposure was adjusted for parental exposure was adjusted for parental historyof schizophrenia, second-trimester historyof schizophrenia, second-trimester viral infections, concomitant drug viral infections, concomitant drug treatment during pregnancy, an index of treatment during pregnancy, an index of pregnancy complications, parental social pregnancy complications, parental social status and parental age. status and parental age.
Results

Results In a risk set of 7999 individuals,
In a risk set of 7999 individuals, 116 cases of schizophrenia were found 116 cases of schizophrenia were found (1.5%).Prenatal exposure to analgesics in (1.5%).Prenatal exposure to analgesics in the second trimester was associated with the second trimester was associated with an elevated risk (adjusted odds ratio 4.75, an elevated risk (adjusted odds ratio 4.75, 95% CI1.9^12.0).Independent of the 95% CI1.9^12.0).Independent of the covariates, the effect remained statistically covariates, the effect remained statistically significant. significant.
Conclusions Conclusions Independent of a wide
Independent of a wide range of possible confounders, a range of possible confounders, a significant association between secondsignificant association between secondtrimester exposure to analgesics and trimester exposure to analgesics and increased risk of schizophrenia was increased risk of schizophrenia was observed. observed.
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Studies strongly suggest that genetic transStudies strongly suggest that genetic transmission accounts for most of the familial mission accounts for most of the familial aggregation of schizophrenia (Gottesman, aggregation of schizophrenia (Gottesman, 1991; Kendler & Diehl, 1993) . Environ-1991; Kendler & Diehl, 1993) . Environmental risk factors have also been implimental risk factors have also been implicated: these include pregnancy and cated: these include pregnancy and delivery complications (Parnas delivery complications (Parnas et al et al, 1982; , 1982; Geddes & Lawrie, 1995) and influenza Geddes & Lawrie, 1995) and influenza during the mother's pregnancy (Mednick during the mother's pregnancy (Mednick et al et al, 1988; O'Callaghan , 1988; O'Callaghan et al et al, 1991; Kunugi , 1991; Kunugi et al et al, 1992; McGrath , 1992; McGrath et al et al, 1994) . Some , 1994) . Some studies have been unable to confirm an studies have been unable to confirm an association between prenatal exposure to association between prenatal exposure to influenza and later schizophrenia (Crow influenza and later schizophrenia (Crow et et al al, 1991; Selten & Slaets, 1994; Susser , 1991; Selten & Slaets, 1994; Susser et et al al, 1994) , and it is conceivable that mater-, 1994), and it is conceivable that maternal intake of medication during pregnancy nal intake of medication during pregnancy to alleviate symptoms associated with influto alleviate symptoms associated with influenza and similar diseases might influence enza and similar diseases might influence the risk of schizophrenia in the offspring. the risk of schizophrenia in the offspring. Thus, maternal intake of analgesics might Thus, maternal intake of analgesics might be related to the offspring's risk of schizobe related to the offspring's risk of schizophrenia. To our knowledge, no study linkphrenia. To our knowledge, no study linking psychiatric morbidity in the offspring ing psychiatric morbidity in the offspring with maternal intake of analgesics during with maternal intake of analgesics during pregnancy has been reported; we therefore pregnancy has been reported; we therefore analysed data from the Copenhagen Perianalysed data from the Copenhagen Perinatal Cohort to examine the associations natal Cohort to examine the associations between schizophrenia in adult life and prebetween schizophrenia in adult life and prenatal exposure to analgesics. natal exposure to analgesics. 
METHOD METHOD
Consumption of medication during Consumption of medication during pregnancy pregnancy
The mothers' reported use of medication The mothers' reported use of medication during pregnancy (information obtained in during pregnancy (information obtained in prenatal and postnatal interviews on any prenatal and postnatal interviews on any medication taken for at least 5 days) was medication taken for at least 5 days) was computerised, using binary indicator varicomputerised, using binary indicator variables without dosage information. The folables without dosage information. The following types of drugs were included in this lowing types of drugs were included in this self-report: antihistamines, barbiturates, self-report: antihistamines, barbiturates, psychoactive medications (this category psychoactive medications (this category included meprobamate, chlordiazepoxide, included meprobamate, chlordiazepoxide, glutethimide, chlorpromazine or perphenaglutethimide, chlorpromazine or perphenazine, imipramine and reserpine), analgesics, zine, imipramine and reserpine), analgesics, chemotherapeutics (sulphonamides, nitrochemotherapeutics (sulphonamides, nitrofurantoin or phenyl salicylate preparations furantoin or phenyl salicylate preparations for disinfection of the urinary tract), for disinfection of the urinary tract), hormones (this category included oestrohormones (this category included oestrogens, progestogens and corticosteroids) gens, progestogens and corticosteroids) and diuretics. and diuretics.
The category of analgesics was The category of analgesics was pharmacologically heterogeneous. It inpharmacologically heterogeneous. It included both prescribed analgesics and cluded both prescribed analgesics and analgesics bought over the counter, and it analgesics bought over the counter, and it was not possible to separate analgesics used was not possible to separate analgesics used for treating fever from those used for treatfor treating fever from those used for treating pain. Aspirin and other antipyretics ing pain. Aspirin and other antipyretics were commonly used; other analgesics inwere commonly used; other analgesics included phenacetin, aspirin in combination cluded phenacetin, aspirin in combination with codeine and, more rarely, stronger with codeine and, more rarely, stronger analgesics such as morphine or synthetic analgesics such as morphine or synthetic forms of morphine. The category of analgeforms of morphine. The category of analgesics also included mixed-formula drugs sics also included mixed-formula drugs containing aspirin-like analgesics in combicontaining aspirin-like analgesics in combination with a smaller amount of opioid nation with a smaller amount of opioid analgesic. Other combinations included analgesic. Other combinations included two types of anti-inflammatory drugs (for two types of anti-inflammatory drugs (for instance antipyrine plus phenacetin) and instance antipyrine plus phenacetin) and analgesics in combination with caffeine. analgesics in combination with caffeine.
The mothers were asked about their The mothers were asked about their intake of analgesics in the first, second intake of analgesics in the first, second and third months and in the second and and third months and in the second and third trimesters of pregnancy. For the study third trimesters of pregnancy. For the study population of 7999 cohort members, the population of 7999 cohort members, the missing data rate was less than 1% for the missing data rate was less than 1% for the first and the third months of pregnancy, first and the third months of pregnancy, and 4.4% for the second month. Inforand 4.4% for the second month. Information on use of analgesics was complete mation on use of analgesics was complete for the second trimester, while the missing for the second trimester, while the missing data rate was 1.7% for the third trimester. data rate was 1.7% for the third trimester. The prevalence of exposure to analgesics at The prevalence of exposure to analgesics at any time during the first trimester was any time during the first trimester was 0.9% (71/7997), during the second 0.9% (71/7997), during the second trimester 1.8% (144/7999) and during the trimester 1.8% (144/7999) and during the third trimester 2.0% (154/7867) third trimester 2.0% (154/7867). Nineteen . Nineteen individuals were exposed exclusively during individuals were exposed exclusively during the first trimester, 58 were exposed excluthe first trimester, 58 were exposed exclusively during the second trimester and 82 sively during the second trimester and 82 were exposed exclusively during the third were exposed exclusively during the third 
Demographic factors Demographic factors
Maternal age (in years) at the time of delivMaternal age (in years) at the time of delivery was obtained from the records at ery was obtained from the records at Rigshospitalet. Information on social status Rigshospitalet. Information on social status was obtained from an interview with the was obtained from an interview with the mother when the child was 1 year old. mother when the child was 1 year old. The socio-economic classification was The socio-economic classification was based on information about breadwinner's based on information about breadwinner's occupation, breadwinner's education, type occupation, breadwinner's education, type of income (wage or salary) and quality of of income (wage or salary) and quality of housing. Sufficient data for classification housing. Sufficient data for classification of social status were available for 6333 of social status were available for 6333 individuals (79.2% of the study popuindividuals (79.2% of the study population). The overall social status mean lation). The overall social status mean was substituted for missing data, and a was substituted for missing data, and a dummy variable was included to indicate dummy variable was included to indicate missing data on social status in the logistic missing data on social status in the logistic regression analyses. regression analyses.
Psychiatric hospitalisation Psychiatric hospitalisation
Written approval to conduct a registryWritten approval to conduct a registrybased psychiatric follow-up was obtained based psychiatric follow-up was obtained from the regional scientific ethics commitfrom the regional scientific ethics committee. Organization, 1967) . The cohort members and their parents were followed members and their parents were followed in the Danish Psychiatric Central Register in the Danish Psychiatric Central Register to identify all hospital admissions with a to identify all hospital admissions with a diagnosis of schizophrenia (ICD-8 code diagnosis of schizophrenia (ICD-8 code 295 or ICD-10 code F20) until December 295 or ICD-10 code F20) until December 1999. In ICD-8, schizophrenia is defined 1999. In ICD-8, schizophrenia is defined by prototypic descriptions of symptoms, by prototypic descriptions of symptoms, such as bizarre delusions, delusions of consuch as bizarre delusions, delusions of control, abnormal affect, autism, hallucinatrol, abnormal affect, autism, hallucinations and disorganised thinking. In 1994, tions and disorganised thinking. In 1994, the more operational ICD-10 criteria were the more operational ICD-10 criteria were implemented (World Health Organization, implemented (World Health Organization, 1992) . The cohort and their parents were 1992). The cohort and their parents were categorised as having a history of schizocategorised as having a history of schizophrenia (ICD-8 code 295 or ICD-10 code phrenia (ICD-8 code 295 or ICD-10 code F20) if they had been admitted with one F20) if they had been admitted with one of these diagnoses. of these diagnoses.
Other variables Other variables
Weighted pregnancy and delivery complicaWeighted pregnancy and delivery complications scales were constructed for use with tions scales were constructed for use with the Copenhagen Perinatal Cohort by a team the Copenhagen Perinatal Cohort by a team of American and Danish obstetricians and of American and Danish obstetricians and paediatric neurologists (Zachau-Christiansen paediatric neurologists (Zachau-Christiansen & Ross, 1975) . To control for pregnancy & Ross, 1975) . To control for pregnancy complications, we used the pregnancy comcomplications, we used the pregnancy complications scale, which included items such plications scale, which included items such as bleeding or illness during pregnancy, as bleeding or illness during pregnancy, use of radiation during pregnancy and use of radiation during pregnancy and pre-eclampsia. Data on viral infections in pre-eclampsia. Data on viral infections in the second trimester were available for the second trimester were available for 7970 pregnancies (99.6% of the study 7970 pregnancies (99.6% of the study population). A few days after delivery, the population). A few days after delivery, the mothers were asked about infections during mothers were asked about infections during the different periods of pregnancy, and the the different periods of pregnancy, and the vast majority of viral infections recorded vast majority of viral infections recorded were minor respiratory illnesses or influenza were minor respiratory illnesses or influenza (Villumsen, 1970) . (Villumsen, 1970) .
We have recently reported that the We have recently reported that the combination of maternal hypertension and combination of maternal hypertension and third-trimester (but not second-trimester) third-trimester (but not second-trimester) intake of diuretics during pregnancy was intake of diuretics during pregnancy was associated with an elevated risk in the offassociated with an elevated risk in the offspring of schizophrenia according to the spring of schizophrenia according to the ICD-8 classification (Sørensen ICD-8 classification (Sørensen et al et al, , 2003) . Both second-trimester and third-2003). Both second-trimester and thirdtrimester exposures to diuretics were trimester exposures to diuretics were included as potential confounders. included as potential confounders.
Statistical analysis Statistical analysis
For each recorded period of gestation (first, For each recorded period of gestation (first, second and third months and second and second and third months and second and third trimesters), we estimated the risk of third trimesters), we estimated the risk of developing schizophrenia in cohort developing schizophrenia in cohort members exposed to analgesics (exposure members exposed to analgesics (exposure group) and in those who were not exposed group) and in those who were not exposed to these drugs (non-exposure group). Subto these drugs (non-exposure group). Subperiods showing an odds ratio significant periods showing an odds ratio significant at the 5% level were included in the at the 5% level were included in the subsequent multivariate analyses. subsequent multivariate analyses.
The distributions of potential confounThe distributions of potential confounders, including parental demographic and ders, including parental demographic and psychiatric characteristics, were compared psychiatric characteristics, were compared between the two groups. One-way analysis between the two groups. One-way analysis of variance was used to compare the disof variance was used to compare the distributions of the continuous variables: tributions of the continuous variables: parental age, parental social status and parental age, parental social status and Pregnancy Complications score. ChiPregnancy Complications score. Chisquared tests were used to compare the prosquared tests were used to compare the proportions of exposures to viral infections portions of exposures to viral infections (second trimester), classes of medication in (second trimester), classes of medication in the second trimester, and the proportions the second trimester, and the proportions of maternal and paternal schizophrenia in of maternal and paternal schizophrenia in the exposure and non-exposure groups. the exposure and non-exposure groups.
The risk of developing schizophrenia The risk of developing schizophrenia associated with prenatal exposure to associated with prenatal exposure to analgesics was estimated in multivariate analgesics was estimated in multivariate logistic regression models. The multivariate logistic regression models. The multivariate analyses included exposure to analgesics in analyses included exposure to analgesics in the first and second trimesters and the folthe first and second trimesters and the following binary variables: second-trimester lowing binary variables: second-trimester exposure to viral infections, other exposure to viral infections, other medication in the second trimester (antimedication in the second trimester (antihistamines, psychoactive medications, histamines, psychoactive medications, barbiturates, chemotherapeutics, hormones barbiturates, chemotherapeutics, hormones and diuretics) and third-trimester exposure and diuretics) and third-trimester exposure to diuretics. In addition, maternal and to diuretics. In addition, maternal and paternal schizophrenia were included as paternal schizophrenia were included as covariates, and the following parameters covariates, and the following parameters were included as continuous covariates 
RESULTS RESULTS
A total of 116 cases of schizophrenia A total of 116 cases of schizophrenia (cumulative incidence 1.5%) were identi-(cumulative incidence 1.5%) were identified. Among 4058 male cohort members, fied. Among 4058 male cohort members, 76 (1.9%) had developed schizophrenia, 76 (1.9%) had developed schizophrenia, and among 3941 female cohort members, and among 3941 female cohort members, 40 (1.0%) had developed schizophrenia. 40 (1.0%) had developed schizophrenia. Table 1 shows that exposure to analge- Table 1 shows that exposure to analgesics in the registered sub-periods of gestasics in the registered sub-periods of gestation was associated with an elevated risk tion was associated with an elevated risk of schizophrenia. For the first trimester of schizophrenia. For the first trimester the odds ratio was only significant for the the odds ratio was only significant for the third month. The odds ratio was also not third month. The odds ratio was also not significant for the third trimester, whereas significant for the third trimester, whereas the cumulative incidence of schizophrenia the cumulative incidence of schizophrenia in the exposure group in the second triin the exposure group in the second trimester was significantly higher than in the mester was significantly higher than in the non-exposure group in that period (5.6% non-exposure group in that period (5.6% v. v. 1.4%;
1.4%; P P5 50.001). Thus, the odds ratio 0.001). Thus, the odds ratio for the second trimester was 4.22 (95% for the second trimester was 4.22 (95% CI 2.0-8.8). CI 2.0-8.8).
Some cohort members were exposed to Some cohort members were exposed to analgesics in more than one period of gestaanalgesics in more than one period of gestation. The total number of cohort members tion. The total number of cohort members who had been exposed at any time during who had been exposed at any time during gestation was 245 (ever exposed), whereas gestation was 245 (ever exposed), whereas 7754 had never been exposed. The unad-7754 had never been exposed. The unadjusted odds ratio associated with exposure justed odds ratio associated with exposure to analgesics at any time during gestation to analgesics at any time during gestation was 2.39 (95% CI 1.2-5.0), whereas it was 2.39 (95% CI 1.2-5.0), whereas it was 2.71 (95% CI 1.3-5.4) when adjusted was 2.71 (95% CI 1.3-5.4) when adjusted for social status, mother's and father's for social status, mother's and father's age, and Pregnancy Complications score. age, and Pregnancy Complications score. Table 2 shows the distribution of demo- Table 2 shows the distribution of demographic and other characteristics of individgraphic and other characteristics of individuals who had ever been exposed to uals who had ever been exposed to analgesics during gestation analgesics during gestation v.
v. the nonthe nonexposed comparison group. Exposure exposed comparison group. Exposure correlated with viral infections, antihistacorrelated with viral infections, antihistamine intake, barbiturate intake and use of mine intake, barbiturate intake and use of psychoactive medication. Moreover, the psychoactive medication. Moreover, the mean parental age and the mean Pregnancy mean parental age and the mean Pregnancy Complications score were higher. The two Complications score were higher. The two groups did not differ with respect to parengroups did not differ with respect to parental social status or proportions of mothers tal social status or proportions of mothers and fathers with schizophrenia. and fathers with schizophrenia.
The relative risks (odds ratios) assoThe relative risks (odds ratios) associated with exposure to analgesics are ciated with exposure to analgesics are shown in Table 3. This table also shows  shown in Table 3 . This table also shows the relative risk associated with exposure the relative risk associated with exposure to viral infection or other medication in to viral infection or other medication in the second trimester and the risk associated the second trimester and the risk associated with maternal or paternal hospitalisation with maternal or paternal hospitalisation with schizophrenia (Table 3 , first column). with schizophrenia (Table 3 , first column). Maternal schizophrenia emerged as the Maternal schizophrenia emerged as the strongest risk factor (adjusted OR strongest risk factor (adjusted OR¼9.27, 9.27, 95% CI 4.7-18.2). The second strongest 95% CI 4.7-18.2). The second strongest effect was noted for second-trimester expoeffect was noted for second-trimester exposure to analgesics (adjusted OR sure to analgesics (adjusted OR¼4.75, 95%
4.75, 95% CI 1.9-12.0). The risk of schizophrenia CI 1.9-12.0). The risk of schizophrenia associated with paternal schizophrenia associated with paternal schizophrenia was lower than expected (adjusted OR was lower than expected (adjusted OR¼ 3.22, 95% CI 0.7-14.1). Similarly, the risk 3.22, 95% CI 0.7-14.1). Similarly, the risk of schizophrenia associated with secondof schizophrenia associated with secondtrimester viral infection was lower than trimester viral infection was lower than expected (adjusted OR expected (adjusted OR¼0.94, 95% CI 0.94, 95% CI 0.4-2.2). 0.4-2.2).
Assuming a causal connection between Assuming a causal connection between prenatal exposure to analgesics and inprenatal exposure to analgesics and increased risk of schizophrenia, the attributacreased risk of schizophrenia, the attributable risk -i.e. the proportion of individuals ble risk -i.e. the proportion of individuals in the total population with the disease in the total population with the disease attributed to exposure to analgesics in the attributed to exposure to analgesics in the second trimester -was calculated (Altman second trimester -was calculated (Altman et al et al, 2000) and found to be 5.2% (95% , 2000) and found to be 5.2% (95% CI 1.8-11.4). CI 1.8-11.4).
The effect of analgesics exposure in the The effect of analgesics exposure in the second trimester was statistically significant second trimester was statistically significant in both genders. The unadjusted odds ratio in both genders. The unadjusted odds ratio was 3.77 (95% CI 1.5-9.6) in males and was 3.77 (95% CI 1.5-9.6) in males and 4.94 (95% CI 1.6-16.4) in females. 4.94 (95% CI 1.6-16.4) in females.
Second-trimester analgesics Second-trimester analgesics exposure and other putative exposure and other putative risk factors risk factors
Out of 7970 cohort members, 464 (5.8%) Out of 7970 cohort members, 464 (5.8%) had been exposed to a viral infection during had been exposed to a viral infection during the second trimester. Six cases of schizothe second trimester. Six cases of schizophrenia (1.3%) emerged among those phrenia (1.3%) emerged among those exposed. There was no interaction between exposed. There was no interaction between second-trimester exposure to analgesics and second-trimester exposure to analgesics and second-trimester viral exposure in relation second-trimester viral exposure in relation to outcome. Only 15 cohort members had to outcome. Only 15 cohort members had both these exposures during the second both these exposures during the second 3 6 8 3 6 8 trimester of gestation, none of whom had a trimester of gestation, none of whom had a subsequent diagnosis of schizophrenia. subsequent diagnosis of schizophrenia. Second-trimester exposure to mediSecond-trimester exposure to medication other than analgesics did not confer cation other than analgesics did not confer an elevated risk of schizophrenia, but an elevated risk of schizophrenia, but third-trimester exposure to diuretics was third-trimester exposure to diuretics was significantly associated with risk of the significantly associated with risk of the disease in the multivariate analysis disease in the multivariate analysis (adjusted OR (adjusted OR¼2.09, 95% CI 1.1-4.2).
2.09, 95% CI 1.1-4.2). The association between exposure to The association between exposure to psychoactive medication in the second tripsychoactive medication in the second trimester and outcome was in the expected dimester and outcome was in the expected direction but was not statistically significant. rection but was not statistically significant. Mothers who took many analgesics might Mothers who took many analgesics might be at higher risk of developing an affective be at higher risk of developing an affective disorder or a substance dependence disordisorder or a substance dependence disorder later in life. Assuming that many with der later in life. Assuming that many with such diagnoses would have been in contact such diagnoses would have been in contact with a psychiatric in-patient facility in with a psychiatric in-patient facility in Denmark after 1969, we decided to carry Denmark after 1969, we decided to carry out additional analyses in a subsample of out additional analyses in a subsample of 6109 cohort members whose mother and 6109 cohort members whose mother and father did not appear in the Danish father did not appear in the Danish Psychiatric Central Register. Those exPsychiatric Central Register. Those excluded were all offspring of mothers or cluded were all offspring of mothers or fathers with a diagnosis of schizophrenia fathers with a diagnosis of schizophrenia or any other psychiatric disorder. In the or any other psychiatric disorder. In the subsample the unadjusted odds ratio of desubsample the unadjusted odds ratio of developing schizophrenia associated with preveloping schizophrenia associated with prenatal exposure to analgesics in the second natal exposure to analgesics in the second trimester was 4.51 (95% CI 1.6-12.7). trimester was 4.51 (95% CI 1.6-12.7).
Out of 144 members of the subsample Out of 144 members of the subsample who had been exposed to analgesics at who had been exposed to analgesics at any time during gestation, 18 people had any time during gestation, 18 people had been exposed to opium or morphine, and been exposed to opium or morphine, and 2 cases of schizophrenia (11.1%) arose in 2 cases of schizophrenia (11.1%) arose in the latter subgroup. A preliminary review the latter subgroup. A preliminary review (data not shown) of some of the original data (data not shown) of some of the original data forms indicated that some of the opioidforms indicated that some of the opioidtreated mothers had undergone abdominal treated mothers had undergone abdominal surgery a short time before. The Pregnancy surgery a short time before. The Pregnancy Complications score for these women was Complications score for these women was higher than the scores for the cohort as a higher than the scores for the cohort as a whole (data not shown). We found no indiwhole (data not shown). We found no indication in the data forms that any of these cation in the data forms that any of these women had ever misused opioids. women had ever misused opioids.
A subgroup of the cohort ( A subgroup of the cohort (n n¼45) had 45) had been exposed to mixed-formula analgesic been exposed to mixed-formula analgesic drugs that contained, among other things, drugs that contained, among other things, older pyrazolone derivatives (antipyrine, older pyrazolone derivatives (antipyrine, isopropylantipyrine, salipyrine, phenaisopropylantipyrine, salipyrine, phenazone, propyphenazone). Four cases of zone, propyphenazone). Four cases of schizophrenia schizophrenia (8.9%) arose in that sub-(8.9%) arose in that subgroup. The unadjusted odds of developing group. The unadjusted odds of developing schizophrenia was 6.74 (95% CI 2.4-schizophrenia was 6.74 (95% CI 2.4-19.1) in those who had been exposed to 19.1) in those who had been exposed to mixed-formula analgesics of this sort and mixed-formula analgesics of this sort and the estimate remained significant when we the estimate remained significant when we adjusted for maternal and paternal age, adjusted for maternal and paternal age, social status and Pregnancy Complications social status and Pregnancy Complications score. score.
DISCUSSION DISCUSSION
Independent of a wide range of potential Independent of a wide range of potential confounders, an association between preconfounders, an association between prenatal exposure to analgesics and risk of natal exposure to analgesics and risk of schizophrenia was observed. The estimate schizophrenia was observed. The estimate of the risk of schizophrenia was more than of the risk of schizophrenia was more than four times greater in individuals who were four times greater in individuals who were exposed to analgesics in the second trimeexposed to analgesics in the second trimester (the association was slightly stronger ster (the association was slightly stronger in females than in males). The association in females than in males). The association was independent of maternal schizowas independent of maternal schizophrenia, which was the strongest risk factor phrenia, which was the strongest risk factor for schizophrenia in this study. for schizophrenia in this study.
From a methodological viewpoint, our From a methodological viewpoint, our prospective study is well suited to examine prospective study is well suited to examine putative associations between prenatal exputative associations between prenatal exposure to medication and adverse outcomes posure to medication and adverse outcomes many years later. Exposure to drug treatmany years later. Exposure to drug treatment was recorded shortly after delivery, ment was recorded shortly after delivery, thus minimising the risk of recall bias. thus minimising the risk of recall bias. The fact that only hospitalised cases of The fact that only hospitalised cases of schizophrenia were identified should not schizophrenia were identified should not be important, as most individuals meeting be important, as most individuals meeting ICD-8 or ICD-10 criteria for schizophrenia ICD-8 or ICD-10 criteria for schizophrenia are admitted to hospital before the age of are admitted to hospital before the age of 40 years. Up to 1994, the (ICD-8) concept 40 years. Up to 1994, the (ICD-8) concept of schizophrenia in Denmark reflected of schizophrenia in Denmark reflected diagnostic caution rather than overdiagnostic caution rather than overinclusiveness. By extending the period of inclusiveness. By extending the period of follow-up beyond 1994, some new cases follow-up beyond 1994, some new cases of schizophrenia were identified using the of schizophrenia were identified using the more operational ICD-10 criteria. more operational ICD-10 criteria.
We are not aware of any previous study We are not aware of any previous study suggesting a link between prenatal exposuggesting a link between prenatal exposure to analgesic drugs and increased risk sure to analgesic drugs and increased risk of severe mental illness. Tentatively, three of severe mental illness. Tentatively, three types of explanations may be considered: types of explanations may be considered:
(a) (a) chemical substances might have caused chemical substances might have caused a subtle disruption of foetal neuroa subtle disruption of foetal neurodevelopment (or interacted with yet development (or interacted with yet unknown genetic liability factors for unknown genetic liability factors for 3 6 9 3 6 9 the disorder) to increase the risk for the disorder) to increase the risk for later development of schizophrenia; later development of schizophrenia; (b) (b) maternal somatic conditions for which maternal somatic conditions for which the mothers took analgesics during the mothers took analgesics during pregnancy might underlie the observed pregnancy might underlie the observed association; association;
(c) (c) the association could be explained by the association could be explained by unidentified factors (which could not unidentified factors (which could not be fully controlled in the analysis) that be fully controlled in the analysis) that correlate with both maternal intake of correlate with both maternal intake of analgesics during pregnancy and analgesics during pregnancy and outcome (residual confounding). outcome (residual confounding).
The unusually high risks of schizophrenia The unusually high risks of schizophrenia (11.1% and 8.9%, respectively) in the (11.1% and 8.9%, respectively) in the small subgroup of offspring of mothers small subgroup of offspring of mothers who were treated with morphine or opioid who were treated with morphine or opioid analgesics and the subgroup with prenatal analgesics and the subgroup with prenatal exposure to mixed-formula analgesics exposure to mixed-formula analgesics could be interpreted as a possible indication could be interpreted as a possible indication of a drug-related effect. Some of the mixedof a drug-related effect. Some of the mixedformula analgesics contained antipyrine formula analgesics contained antipyrine and related substances. The derivatives of and related substances. The derivatives of these substances undergo extensive metabothese substances undergo extensive metabolisation in humans. Little toxicological lisation in humans. Little toxicological information on their embryotoxic and information on their embryotoxic and teratogenic properties exists for these subteratogenic properties exists for these substances (Burdan, stances (Burdan, 2002) . However, to 2002). However, to establish a drugestablish a drug-associated risk of a speciassociated risk of a specific adult outcome in a non-experimental fic adult outcome in a non-experimental setting requires comparability of the exposetting requires comparability of the exposed and non-exposed groups. The abovesed and non-exposed groups. The abovementioned small subgroups may not be mentioned small subgroups may not be comparable with the pool of non-exposed comparable with the pool of non-exposed cohort controls on all the characteristics cohort controls on all the characteristics thought relevant to the development of thought relevant to the development of schizophrenia. schizophrenia.
It is attractive to speculate that It is attractive to speculate that in utero in utero exposure to one or several types of analgeexposure to one or several types of analgesics could be implicated in disruption of sics could be implicated in disruption of foetal neurodevelopment. During the foetal neurodevelopment. During the second trimester of pregnancy, the cortical second trimester of pregnancy, the cortical subplate reaches its peak of development subplate reaches its peak of development (Akbarian (Akbarian et al et al, 1995) . This may be a peri- , 1995) . This may be a period when the immature brain is particularly od when the immature brain is particularly sensitive to a range of intrauterine sensitive to a range of intrauterine environmental influences. environmental influences.
Based on data from the Copenhagen Based on data from the Copenhagen Perinatal Cohort, Villumsen noted that the Perinatal Cohort, Villumsen noted that the incidence of malformed offspring of incidence of malformed offspring of mothers who did not take medication durmothers who did not take medication during pregnancy was 3.6%, whereas the inciing pregnancy was 3.6%, whereas the incidence of malformed children in offspring of dence of malformed children in offspring of mothers who had taken analgesics was mothers who had taken analgesics was 7.4% (Villumsen, 1970) . This is of poten-7.4% (Villumsen, 1970) . This is of potential relevance to theories on aetiological tial relevance to theories on aetiological factors in schizophrenia as well. A large factors in schizophrenia as well. A large number of minor physical anomalies number of minor physical anomalies (high-steepled palate, large or small dis-(high-steepled palate, large or small distance between tear ducts, adherent earlobes) tance between tear ducts, adherent earlobes) have been linked to schizophreniahave been linked to schizophrenia-spectrum spectrum disorders in a subsample of the Copenhadisorders in a subsample of the Copenhagen Perinatal Cohort (Schiffman gen Perinatal Cohort (Schiffman et al et al, , 2002) . It has even been suggested that com-2002). It has even been suggested that common genetic or environmental factors might mon genetic or environmental factors might be associated with schizophrenia and conbe associated with schizophrenia and congenital malformations (Goodman, 1996; genital malformations (Goodman, 1996; Ismail Ismail et al et al, 1998) . , 1998). We observed no difference in the proWe observed no difference in the proportions of maternal and paternal schizoportions of maternal and paternal schizophrenia in analgesic-exposed and nonphrenia in analgesic-exposed and nonexposed cohort members. The mothers of exposed cohort members. The mothers of the two groups did, however, differ in other the two groups did, however, differ in other important aspects. Maternal intake of psyimportant aspects. Maternal intake of psychotropic drugs during the second trimester chotropic drugs during the second trimester correlated with intake of analgesics in the correlated with intake of analgesics in the same period. Intake of these medications same period. Intake of these medications might be associated with higher psychiatric might be associated with higher psychiatric morbidity and/or a tendency to consult a morbidity and/or a tendency to consult a physician more often. When the cohort physician more often. When the cohort was established, few Danish women conwas established, few Danish women consumed alcohol and the use of illicit drugs sumed alcohol and the use of illicit drugs was extremely rare. Consequently, data was extremely rare. Consequently, data were not collected on maternal alcohol or were not collected on maternal alcohol or illicit drug use during pregnancy. illicit drug use during pregnancy.
Maternal viral infection in the second Maternal viral infection in the second trimester was not significantly associated trimester was not significantly associated with schizophrenia, but in this study statiswith schizophrenia, but in this study statistical power might not have been sufficient tical power might not have been sufficient to detect such a relationship. As mentioned to detect such a relationship. As mentioned previously, only 15 cohort members had previously, only 15 cohort members had been exposed to both viral infection and been exposed to both viral infection and maternal analgesics, and consequently maternal analgesics, and consequently statistical power is also a concern when statistical power is also a concern when interpreting the non-significance of the interpreting the non-significance of the interaction between these two factors. interaction between these two factors. The association between prenatal exposure to analgesics and increased risk of schizophrenia was independent of other known risk factors for the disorder. schizophrenia was independent of other known risk factors for the disorder. It would have required a larger cohort study and the collection of additional prenatal and perinatal data to disentangle effects of prenatal exposure to analgesic prenatal and perinatal data to disentangle effects of prenatal exposure to analgesic drugs from the effects of the somatic and psychosomatic conditions prompting their drugs from the effects of the somatic and psychosomatic conditions prompting their use. use.
LIMITATIONS LIMITATIONS
& & The study lacked adequate statistical power to test whether differential effects of The study lacked adequate statistical power to test whether differential effects of particular analgesic substances were present. particular analgesic substances were present. The data on prenatal exposure to medication dates back to the early 1960s and some of the drugs used at that time are now obsolete in most countries. some of the drugs used at that time are now obsolete in most countries. No information on the dosage of the drugs taken during the pregnancy was available. available.
In conclusion, prenatal exposure to anIn conclusion, prenatal exposure to analgesics in the second trimester of pregalgesics in the second trimester of pregnancy conferred a more than four-fold nancy conferred a more than four-fold greater risk of schizophrenia. However, greater risk of schizophrenia. However, only 6.9% of all the cohort members with only 6.9% of all the cohort members with schizophrenia had been exposed to analgeschizophrenia had been exposed to analgesics in the second trimester. Replication of sics in the second trimester. Replication of this research by other investigators is this research by other investigators is clearly needed before prenatal exposure clearly needed before prenatal exposure to analgesics can be added to the list to analgesics can be added to the list of demonstrated risk factors for of demonstrated risk factors for schizophrenia. schizophrenia.
